9
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Role of combined oral contraceptives in women undergoing assisted reproduction treatment

&
Pages 495-499 | Published online: 10 Jan 2014

References

  • Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas30(2), 137–142 (1998).
  • Gougeon A. Some aspects of the dynamics of ovarian follicular growth in the human. Acta Eur. Fertil.20(4), 185–192 (1989).
  • McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr. Rev.21(2), 200–214 (2000).
  • Webb R, Campbell BK. Development of the dominant follicle: mechanisms of selection and maintenance of oocyte quality. Soc. Reprod. Fertil. (Suppl. 64), 141–163 (2007).
  • Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr. Rev.17(2), 121–155 (1996).
  • van den Hurk R, Zhao J. Formation of mammalian oocytes and their growth, differentiation and maturation within ovarian follicles. Theriogenology63(6), 1717–1751 (2005).
  • Marcus SF, Ledger WL. Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. Hum. Fertil. (Camb.)4(2), 85–93 (2001).
  • Janssens RM, Lambalk CB, Vermeiden JP et al. Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study. Hum. Reprod.15(11), 2333–2340 (2000).
  • Sonntag B, Kiesel L, Nieschlag E, Behre HM. Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART. J. Assist. Reprod. Genet.22(7–8), 277–283 (2005).
  • Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil. Steril.84(3), 555–569 (2005).
  • Fauser BC, Diedrich K, Devroey P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum. Reprod. Update14(1), 1–14 (2008).
  • Pan HA, Wu MH, Cheng YC, Wu LH, Chang FM. Quantification of ovarian Doppler signal in hyperresponders during in vitro fertilization treatment using three-dimensional power Doppler ultrasonography. Ultrasound Med. Biol.29(7), 921–927 (2003).
  • Mathur R, Evbuomwan I, Jenkins J. Prevention and management of ovarian hyperstimulation syndrome. Curr. Obstet. Gynaecol.15(2), 132–138 (2005).
  • Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol. Metab.18(2), 58–65 (2007).
  • Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update.12(6), 685–718 (2006).
  • Hendriks DJ, Mol BW, Bancsi LF, Te Velde ER, Broekmans FJ. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil. Steril.83(2), 291–301 (2005).
  • Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-Müllerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG112(10), 1384–1390 (2005).
  • van Rooij IA, Broekmans FJ, te Velde ER et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum. Reprod.17(12), 3065–3071 (2002).
  • Mishell DR Jr, Kletzky OA, Brenner PF, Roy S, Nicoloff J. The effect of contraceptive steroids on hypothalamic–pituitary function. Am. J. Obstet. Gynecol.128(1), 60–74 (1977).
  • ESHRE Capriworkshop Group. Ovarian and endometrial function during hormonal contraception. Hum. Reprod.16(7), 1527–1535 (2001).
  • van der Spuy ZM, Sohnius U, Pienaar CA, Schall R. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. Contraception42(6), 597–609 (1990).
  • Montloin A. Oral contraception. Rev. Infirm.40(18), 46–52 (1990).
  • Schlaff WD, Lynch AM, Hughes HD, Cedars MI, Smith DL. Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am. J. Obstet. Gynecol.190(4), 943–951 (2004).
  • van Heusden AM, Fauser BC. Activity of the pituitary–ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. Contraception59(4), 237–243 (1999).
  • Huirne JA, van Loenen AC, Donnez J et al. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod. Biomed. Online13(2), 235–245 (2006).
  • Barmat LI, Chantilis SJ, Hurst BS, Dickey RP. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil. Steril.83(2), 321–330 (2005).
  • Huirne JA, Hugues JN, Pirard C et al. Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, Phase IIIb study. Hum. Reprod.21(6), 1408–1415 (2006).
  • Ramsewak SS, Duffy S, Taylor J, Woodward B. The oral contraceptive pill effectively permits cycle batching for an intermittent in vitro fertilization programme in Trinidad and Tobago. West Indian Med. J.54(2), 127–129 (2005).
  • Smulders B, van Oirschot SM, Farquhar C, Rombauts L, Kremer JA. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database Syst. Rev.1, CD006109 (2010).
  • Cedrin-Durnerin I, Bstandig B, Parneix I et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum. Reprod.22(1), 109–116 (2007).
  • Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum. Reprod.21(2), 352–357 (2006).
  • Keltz MD, Gera PS, Skorupski J, Stein DE. Comparison of FSH flare with and without pretreatment with oral contraceptive pills in poor responders undergoing in vitro fertilization. Fertil. Steril.88(2), 350–353 (2007).
  • Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil. Steril.70(6), 1063–1069 (1998).
  • Gelety TJ, Pearlstone AC, Surrey ES. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women. Fertil. Steril.64(6), 1074–1080 (1995).
  • Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum. Reprod.26(7), 1616–1624 (2011).
  • Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum. Reprod.12(11), 2359–2365 (1997).
  • Franks S. The ubiquitous polycystic ovary. J. Endocrinol.129(3), 317–319 (1991).
  • Frederick J, DaCosta V, Wynter S, Reid M, Frederick C, McKenzie C. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation. West Indian Med. J.53(1), 39–43 (2004).
  • Griesinger G, Venetis CA, Marx T, Diedrich K, Tarlatzis BC, Kolibianakis EM. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil. Steril.90(4), 1055–1063 (2008).
  • Bellver J, Albert C, Labarta E, Pellicer A. Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment. Fertil. Steril.87(5), 1098–1101 (2007).
  • van den Berg MH, van Dulmen-den Broeder E, Overbeek A et al. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum. Reprod.25, 1520–1527 (2010).
  • Jayaprakasan K, Hopkisson JF, Campbell BK, Clewes J, Johnson IR, Raine-Fenning NJ. Quantification of the effect of pituitary down-regulation on 3D ultrasound predictors of ovarian response. Hum. Reprod.23(7), 1538–1544 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.